191 related articles for article (PubMed ID: 29691085)
1. The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.
Li RD; Tang YH; Wang HL; Yang D; Sun LJ; Li W
Pathol Res Pract; 2018 May; 214(5):625-630. PubMed ID: 29691085
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma.
Binh MT; Hoan NX; Giang DP; Tong HV; Bock CT; Wedemeyer H; Toan NL; Bang MH; Kremsner PG; Meyer CG; Song LH; Velavan TP
Sci Rep; 2020 Feb; 10(1):2797. PubMed ID: 32071406
[TBL] [Abstract][Full Text] [Related]
3. SMYD3 tandem repeats polymorphism is not associated with the occurrence and metastasis of hepatocellular carcinoma in a Chinese population.
Wang XQ; Miao X; Cai Q; Garcia-Barcelo MM; Fan ST
Exp Oncol; 2007 Mar; 29(1):71-3. PubMed ID: 17431393
[TBL] [Abstract][Full Text] [Related]
4. SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer.
Liu TT; Xu H; Gao WP; Zhang SX; Zhou XH; Tang J; Liu QN
Med Sci Monit; 2016 Dec; 22():5131-5140. PubMed ID: 28024138
[TBL] [Abstract][Full Text] [Related]
5. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
6. Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype study.
Al-Eitan LN; Rababa'h DM
Gene; 2020 Feb; 728():144281. PubMed ID: 31836525
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma.
Fei X; Ma Y; Liu X; Meng Z
Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705
[TBL] [Abstract][Full Text] [Related]
8. Effects of interactions between environmental factors and KIF1B genetic variants on the risk of hepatocellular carcinoma in a Chinese cohort.
Chen JH; Wang YY; Lv WB; Gan Y; Chang W; Tian NN; Huang XH; Liu L; Yu XF; Chen SD
World J Gastroenterol; 2016 Apr; 22(16):4183-90. PubMed ID: 27122668
[TBL] [Abstract][Full Text] [Related]
9. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-Related 5 Gene rs510432 Polymorphism Is Associated with Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection.
Li N; Fan X; Wang X; Deng H; Zhang K; Zhang X; Han Q; Lv Y; Liu Z
Immunol Invest; 2019 May; 48(4):378-391. PubMed ID: 30907204
[TBL] [Abstract][Full Text] [Related]
11. The relationship between TNF alpha gene polymorphisms (-238/-308), TNF RII VNTR (p75) and outcomes of hepatitis B virus infection in Tunisian population.
Sghaier I; Zidi S; Mouelhi L; Dabbech R; Ghazouani E; Brochot E; Stayoussef M; Yacoubi-Loueslati B
Gene; 2015 Sep; 568(2):140-5. PubMed ID: 25982858
[TBL] [Abstract][Full Text] [Related]
12. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
[TBL] [Abstract][Full Text] [Related]
13. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
14. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
[TBL] [Abstract][Full Text] [Related]
15. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis.
Li XD; Li ZG; Song XX; Liu CF
Pathology; 2010 Dec; 42(7):669-73. PubMed ID: 21080878
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2E1 variable number tandem repeat polymorphisms and health risks: a genotype-phenotype study in cancers associated with drinking and/or smoking.
Catanzaro I; Naselli F; Saverini M; Giacalone A; Montalto G; Caradonna F
Mol Med Rep; 2012 Aug; 6(2):416-20. PubMed ID: 22614694
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
[TBL] [Abstract][Full Text] [Related]
18. SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.
Zhang H; Zheng Z; Zhang R; Yan Y; Peng Y; Ye H; Lin L; Xu J; Li W; Huang P
Cell Death Dis; 2021 Jul; 12(8):731. PubMed ID: 34301921
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma.
Liu W; Ma N; Zhao D; Gao X; Zhang X; Yang L; Liu D
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):446-450. PubMed ID: 30683632
[TBL] [Abstract][Full Text] [Related]
20. Association analysis between the c.1804C>A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population.
Liu Y; Zhang A; Liu Y; Dong J
Med Oncol; 2014 Mar; 31(3):854. PubMed ID: 24526467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
